Skip to search formSkip to main contentSkip to account menu

Gelucire 50-13

Known as: G 50-13 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Fatty acid glycerol estersOils

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Gelucire Based In Situ Gelling Emulsions: A Potential Carrier for Sustained Stomach Specific Delivery of Gastric Irritant Drugs
Non steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications to the geriatric patients for the treatment of… 
2012
2012
Suitability of Gelucire 50/13 for controlled release formulation of salbutamol sulphate.
Gelucire 50/13 (G50/13) was assessed to develop controlled release formulation of salbutamol sulphate (SBL) a highly water… 
2011
2011
Title : Improvement of Solubility and Dissolution Rate of Indomethacin by Solid Dispersions in Gelucire 50 / 13 and PEG 4000
2003
2003
Controlled Release Behaviour of Nifedipine from the Pellets of Gelucire/Microcrystalline Cellulose Blends
The aim of the present study was to prepare matrix pellets loaded nifedipine (NF) as model drug by pellitization technique by… 
2002
2002
Enhanced Dissolution Rate of Tiaprofenic Acid Using Gelucire®44/14*
Tiaprofenic acid (TA), racemic (5-benzoyl-2-thieny1)-propionic acid (Fig. 1) is a 2-aryl propionic acid derivative nonsteroidal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)